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1. Introduction  
Primary hyperparathyroidism (PHPT) is caused by overproduction of parathyroid hormone 
(PTH) by at least 1 autonomously functioning parathyroid gland. Such overproduction results 
in increased blood calcium levels because of increased renal absorption, increased vitamin D 
synthesis (and calcium absorption in the gastrointestinal tract), and increased bone resorption. 
(Felger, Johnson) PHPT is caused by a single parathyroid adenoma 80% to 85% of the time. 
(Pyrah) Less frequently, it is caused by multiple adenomas or multigland hyperplasia (MGH). 
Intraoperatively, MGH may be difficult to differentiate from an adenoma, because hyperplasia 
may occasionally be asymmetric. (Kaplan) PHPT is generally a benign disease, but parathyroid 
carcinoma accounts for 0.5% of cases. The majority of PHPT cases are sporadic, but PHPT may 
also be associated with familial syndromes, including familial PHPT and multiple endocrine 
neoplasia type I and IIA. (Johnson)  
2. Embryology  
Most normal parathyroid glands (parathyroids for short) weigh between 35 and 50 mg, are 
under 5 mm in diameter, and are yellowish-brown. (Pyrah, Johnson) The upper parathyroids 
develop embryologically from the fourth branchial pouches. They descend with the thyroid 
into the neck and tend to have a fairly consistent location in the posterior portion of the middle 
third of the thyroid, just above the intersection of the inferior thyroid artery and recurrent 
laryngeal nerve. (Pyrah) Ectopic superior parathyroids may be found in the tracheoesophageal 
groove; in the retropharyngeal or retroesophageal space; posterior mediastinum; in the carotid 
sheath; or within the thyroid itself (intrathyroidal). (Johnson) Inferior parathyroids derive from 
the third branchial pouch, descend with the thymus, and are typically found on the posterior 
portion of the lower pole of the thyroid. However, ectopic inferior parathyroids may be 
submandibular, intrathymic, or intrathyroidal, or may be found in the thyrothymic ligament 
or anterior mediastinum. (Pyrah) Supernumerary parathyroids are found in 13% of cases; 
fewer than 4 of them are found in about 3% of cases. (Johnson) 
3. Diagnosis  
PHPT commonly affects individuals between the ages of 30 and 60 years—and women by a 3-
to-1 ratio. (Kaplan) In outpatients, it is the most frequent cause of hypercalcemia. It is typically 
identified as hypercalcemia on routine laboratory evaluation in a seemingly asymptomatic 
individual. Symptoms may include weakness, easy fatigability, muscle aches, weight loss, 
www.intechopen.com
 Thyroid and Parathyroid Diseases – New Insights into Some Old and Some New Issues 204 
irritability, depression, constipation, epigastric pain, nausea, vomiting, polyuria, renal colic, 
arthralgias, bony aches, pruritus, and paresthesias. Less common are the supposedly classic 
symptoms known by this rhyming mnemonic: stones, bones, groans, and psychic overtones 
(for renal calculi, osteoporosis, abdominal pain, and neuropsychiatric symptoms). If left 
untreated, patients with PHPT are at risk for hypertension, peptic ulcers, pancreatitis, 
nephrolithiasis, gout, and pathologic fractures. Patients typically present in one of three 
groups: those with osteitis fibrosa, those with nephrolithiasis, and those who are 
asymptomatic and whose disease is incidentally found. Those with osteitis fibrosa tend to 
have more symptoms and higher concentrations of PTH. (Mallette)  
Most cases of PHPT are diagnosed incidentally, when hypercalcemia is identified on routine 
blood work. Hypercalcemia with an elevated PTH level confirms the diagnosis of PHPT. 
Some patients have a PTH level within the normal range, but the level is inappropriately 
high relative to the serum calcium level. (Mallette) In patients with symptoms suggestive of 
PHPT, the serum calcium level (corrected for albumin) should be checked and compared 
with the specific laboratory reference range. (Chan, Kaplan, Glendenning) The ionized 
calcium level may also be obtained, because that level is not affected by binding globulins, 
transfusions, venous stasis, or gadolinium. (Glendenning)  
If the serum or ionized calcium level is elevated, other causes must be considered, such as 
milk-alkali syndrome, malignancy, sarcoidosis, hyperthyroidism, hypervitaminosis D, and 
many primary bone disorders. (Keating) In addition, the PTH level (via second- or third-
generation assays) should be measured. (Chan AK, Bilezikian) In young patients and in 
patients of any age who have family members with hypercalcemia, the urinary calcium level 
should also be obtained, in order to evaluate for familial hypocalciuric hypercalcemia (FHH). 
(Kaplan) A Ca/Cr ratio of less than 0.01 is diagnostic of FHH; a ratio of more than 0.02 
confirms PHPT. (Glendenning) Other laboratory abnormalities associated with PHPT include 
hypophosphatemia, hyperchloremic acidosis, hypomagnesemia, elevated alkaline 
phosphatase levels, and increased urinary calcium excretion. Moreover, 25-hydroxy vitamin D 
levels should be checked, in order to identify coexisting vitamin D deficiency. (Mallette) 
Classic symptoms Associated symptoms Associated conditions 
Renal calculi 
Osteoporosis 
Abdominal pain 
Neuropsychiatric symptoms 
Weakness 
Easy fatigability 
Muscle aches 
Weight loss 
Irritability 
Depression 
Constipation 
Epigastric pain 
Nausea 
Vomiting 
Polyuria 
Renal colic 
Arthralgias 
Bony aches 
Pruritus 
Paresthesias 
Hypertension 
Peptic ulcers 
Pancreatitis 
Nephrolithiasis 
Gout 
Pathologic fractures 
Osteitis fibrosa 
Table 1. Symptoms of PHPT 
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4. Surgical indications 
An operation can be helpful in patients with PHPT in order to restore their calcium balance 
and euparathyroid state. Postoperatively, most symptoms resolve, especially osteitis fibrosa. 
(Kaplan)  
Preoperatively, all patients should begin, or continue, treatment for any concomitant 
diseases, such as angina, hypertension, and diabetes. They should be adequately hydrated, 
especially if they have significant hypercalcemia. In addition, their calcium level and renal 
function should be evaluated. It is also a good idea to assess bone mineral density, which 
gives an idea of the chronicity of a given patient’s PHPT and the potential need for 
antiresorptive therapy postoperatively. (Davies) 
4.1 Symptomatic PHPT  
In patients with confirmed PHPT who can tolerate surgery, symptoms are one of the main 
indications. (Kaplan, Bilezikian) Those with renal involvement benefit from a 
parathyroidectomy, in order to reduce the risk of nephrolithiasis and to help improve renal 
function. Those with pancreatitis should be offered a parathyroidectomy; without one, the 
risk of disease recurrence and of significant complications is significant. Those with osteitis 
fibrosa and osteoporosis also benefit from a parathyroidectomy, which improves cortical 
and trabecular bone symptoms, though not always bone mineral density. A 
parathyroidectomy also decreases the risk of a pathologic fracture and lessens muscle 
weakness and fatigue. In addition, it helps avoid a hypercalcemic crisis. (Davies)  
Reviewing the records of their own patients and other studies, Kaplan et al. found that 100% 
of patients with osteitis and pancreatitis saw improvement after a parathyroidectomy. And 
about 90% of patients with nephrolithiasis saw improvement, although renal function 
improved only variably (in 0% to 43% of patients). Other symptoms of PHPT also improved 
only variably, specifically peptic ulcers, hypertension, neuropsychiatric symptoms, and 
constipation. (Kaplan) 
 
Renal involvement 
Pancreatitis 
Osteitis fibrosa 
Osteoporosis 
Bone Fracture 
Muscle weakness 
Fatigue 
Hypercalcemic crisis 
 
Table 2. Indications for surgery: symptomatic PHPT 
4.2 Asymptomatic PHPT 
In most asymptomatic patients, if they are not treated surgically, PHPT will eventually 
progress; in many of them, bone mineral density (BMD) will decrease. Such patients are also 
potentially at risk for cardiovascular and neurocognitive problems, and they have lower 
quality of life scores and more psychological symptoms. (Bilezikian)  
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Asymptomatic PHPT should be treated surgically if the patient meets the criteria set by the 
Task Force on Primary Hyperparathyroidism of the American Association of Clinical 
Endocrinologists and the American Association of Endocrine Surgeons (AACE/AAES). The 
criteria are as follows: patient age under 50 years, serum calcium level more than 1 mg/dL 
above the upper limit of normal, creatinine clearance less than 30% below age-matched 
norms, decreased BMD (T or Z score under -2.5), and difficulty with medical follow-up. 
(Felger, Bilezikian, Kukora)  
In the past, hypercalciuria (excretion of more than 400 mg/day of calcium) was an 
indication for surgery--even in the absence of renal stones; it is no longer an indication, 
according to a summary statement from the Third International Workshop on 
Asymptomatic PHPT. (Bilezikian)  
Most asymptomatic patients have improved symptoms postoperatively. (Felger) The reason 
is probably that many patients with hyperparathyroidism suffer preoperatively from 
weakness, easy fatigability, depression, neurocognitive dysfunction, and increased sleep 
requirements; still, it is impossible to predict which patients will benefit from surgery. 
(Bilezikian) Surgeons adhering to the National Institutes of Health (NIH) surgical 
indications criteria have noticed a cure rate of 95% to 98%, with a risk of complications of 
only 1% to 2%. (Sosa, Kukora) Some groups feel that the criteria for a parathyroidectomy are 
too limited, and that more patients would benefit from it. (Sywak)  
 
Patient age < 50 years 
Serum calcium level > 1 mg/dL above the upper limit of normal 
Creatinine clearance < 30% below age-matched norms 
Decreased BMD (T or Z score under -2.5) 
Difficulty with medical follow-up 
 
Table 3. Indications for surgery: asymptomatic PHPT 
5. Preoperative imaging 
The choice of preoperative imaging for patients with PHPT is often controversial. Without 
imaging, in the hands of an experienced surgeon, a patient undergoing a bilateral neck 
exploration for PHPT typically has a cure rate of 95% to 98%. (Shaha) But given the ability to 
perform minimally invasive surgery, preoperative imaging is gaining importance. (Shaha, 
Johnson) Such imaging can lead to the discovery of ectopic parathyroids and other 
pathology (such as other cervical masses). (Lumachi) 
Imaging is most valuable for patients who require a reoperation for persistent or recurrent 
PHPT. Other populations who particularly benefit from preoperative localization via 
imaging include asymptomatic patients who previously underwent related neck surgery 
(such as a thyroidectomy or neck dissection); patients with difficult anatomic issues (such as 
those who are obese with a short neck); and patients at high operative risk. (Shaha)  
Currently, sestamibi and ultrasound studies are the most common preoperative imaging 
modalities, but other imaging modalities are being more readily utilized. 
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5.1 Sestamibi scans 
A sestamibi scan is a scintigraphic study; sestamibi was first noted to be taken up by the 
parathyroids when the study was used to evaluate cardiac perfusion. Since then, it has been 
thought to be a valuable tool for preoperative evaluation of the parathyroids. It uses 
technetium-99m hexakis-methoxyisobutyl isonitrile as the radionucleotide. The technetium 
is taken up by both the thyroid and parathyroids, so iodine (I123) is used for thyroid 
subtraction. Initially, the study was performed with thallium technetium; however, 
sestamibi has a higher affinity for abnormal parathyroids. A sestamibi scan result is deemed 
positive if it pinpoints a “hot focus” on the initial and/or the delayed image of the 
parathyroids (but not on the thyroid scan). (Shaha)  
One group noted that the accuracy of the sestamibi scan is 80% and the positive predictive 
value is 89%. (Shaha) Its sensitivity for identifying solitary adenomas ranges from 68% to 
95%. (Johnson) However, it is able to identify only 30% of patients with double adenomas. 
As a single modality, it has a higher sensitivity than other imaging modalities for identifying 
solitary adenomas. However, false-positives may be due to thyroid nodules, lymph nodes, 
and brown adipose. (Mihai) 
Using the sestamibi scan to preoperatively locate abnormal parathyroids is thought to 
improve the cure rate of PHPT, decrease operative time, and allow the possibility of a 
minimally invasive parathyroidectomy; however, such speculation is not always supported 
in the literature. Patients with negative sestamibi scan results are more likely to have lower 
operative cure rates (92%) than those whose scans showed a distinct adenoma (99%). 
(Allendorf) The scan result is more likely to be positive for adenomas in the face of higher 
calcium and PTH levels, higher oxyphil concentration, and vitamin D deficiency. Patients 
who are taking a calcium channel blocker are more likely to have a negative sestamibi scan 
result. Radiotracer retention is necessary in order for the sestamibi scan result to be positive; 
therefore, patients with high levels of P-glycoprotein (a multidrug resistance protein) are 
likely to have a negative result. (Mihai) 
Pros Cons 
Highest sensitivity as single modality 
Positive results suggestive of higher cure 
Visualization of one focus allows facilitates 
minimally invasive parathyroidectomy 
False-positives due to thyroid nodules, 
lymph nodes, and brown adipose 
False-negatives in patients on calcium 
channel blockers, high P-glycoprotein, 
and drug resistance genes 
Table 4. Pros and Cons of Sestamibi Scans 
5.2 Ultrasound (US) scans 
An US study performed with a high-frequency transducer is used to comprehensively 
evaluate the neck from the hyoid bone to the thoracic inlet. The thyroid is imaged as well, 
looking for nodules or intrathyroidal parathyroids. Doppler is added to image the vascular 
structures and to visualize vessels supplying adenomas. In obese patients, graded 
compression can be used to assist in visualization. (Johnson)  
US has a sensitivity for finding solitary adenomas of 72% to 89%. On US, adenomas appear 
homogenous and hypoechoic. They are most frequently seen if they are at least 10 mm. 
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Sometimes the blood supply of the adenoma can be visualized with Doppler: frequently a 
rim of vascularity at the periphery of the gland is seen. Normal parathyroids are small 
(about 5 mm) and are rarely seen on ultrasound. It can be difficult to diagnose hyperplasia 
with US, since the parathyroids are not markedly enlarged. Retrotracheal and mediastinal 
ectopic parathyroids are not well visualized on US. (Johnson)  
Another difficulty is differentiating cervical lymph nodes from parathyroids; the two can be 
mistaken for each other. Nodes typically have a fatty hilum and are supplied by small hilar 
vessels. Thyroid nodules, especially those posteriorly located, can also be difficult to 
differentiate from parathyroids. Thyroid nodules do not typically display a vascular pattern. 
Intrathyroid parathyroids are also difficult to discern from thyroid nodules. (Johnson) 
Diagnostic fine-needle aspiration of thyroid nodules helps differentiate parathyroids from 
other cervical nodules. (Dimashkieh) 
Individually, sestamibi and US studies have limited accuracy, but the use of both imaging 
modalities increases the ability to successfully identify a single adenoma: the reported 
combined sensitivity is 95%. (Lumachi, 2000) When the results of both the sestamibi and 
US studies are concordant, the accuracy for identifying a single adenoma can be as high as 
98%. (Haciyanli) 
Pros Cons 
Anatomic study 
Identifies concomitant thyroid 
disease 
Intraoperative use 
Difficulty visualizing normal glands 
Mistaking of thyroid nodules and lymph 
nodes for adenomas 
Difficulty in identifying multigland 
disease 
Table 5. Pros and Cons of US Scans 
5.3 Computed tomography (CT)  
CT of the neck and mediastinum is very good for recognizing enlarged glands, with 
sensitivity from 76% to 83%. Despite its accuracy, CT is infrequently used because of the 
associated radiation exposure and the need to give intravenous (IV) contrast. However, it 
can help predict four-gland hyperplasia (necessitating bilateral neck exploration) more 
frequently than other imaging modalities. It has also been shown to pick up some 
parathyroid adenomas previously missed on ultrasound scans. (Lumachi, 2004)  
CT is efficacious when combined with sestamibi scans: their combined sensitivity nears 
100%. (Lumachi, 2004)  
SPECT/CT is an emerging technology that allows better definition of scintigraphic images; its 
sensitivity for defining parathyroid lesions preoperatively is close to 88%. (Neumann) (SPECT 
stands for single-photon- emission CT.) It is most beneficial when patients have had a prior 
operation and when anatomic details matched with functional information from sestamibi 
scans are required. It is also very useful for identifying ectopic parathyroids. (Krauz)  
A new method, called 4D-CT, uses CT anatomic images combined with functional images. 
Its purported sensitivity is 88%, higher than the individual sensitivities of sestamibi and US 
scans. 4D-CT is very beneficial for identifying multigland disease. (Mihai)  
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5.4 Positron emission tomography (PET) 
A newer form of PET called [18F]-2-fluorodeoxyglucose (FDG)-PET can be helpful with 
parathyroid imaging. FDG-PET uses a methionine-labeled radiotracer that has good 
specificity for hyperfunctioning parathyroid tissue. It is helpful in patients who have had a 
negative result on localization imaging studies or who need a reoperation. Its sensitivity is 
86%, but increases to 92% when coupled with CT. (Mihai)  
5.5 Magnetic resonance imaging (MRI)  
MRI can be used in a similar manner to CT to diagnose the cause of PHPT. (Johnson) It has 
not been used frequently or studied extensively in patients with PHPT, but its sensitivity 
ranges from 71% to 100%. MRI may be especially useful if paired with a sestamibi scan or 
with a methoxyisobutylisonitrile (MIBI) scan for enhanced accuracy, though no protocols 
have yet been developed for such combinations. (Mihai)  
Image Modality Sensitivity 
Sestamibi 68-95% 
US 72-89% 
CT 76-83% 
PET 86% 
MRI 70-100% 
Combined Sestamibi and US 95% 
Combined CT and Sestamibi 100% 
Combined PET and CT 92% 
Table 6. Sensitivities of Imaging Modalities 
6. Adjuncts in parathyroid surgery  
As minimally invasive procedures become more popular, the need becomes greater to 
provide minimally invasive parathyroidectomies. With a minimally invasive 
parathyroidectomy, as previously mentioned, preoperative imaging is necessary in order to 
determine which gland needs to be removed. Additionally, intraoperative adjuncts 
(described below) are frequently used in order to decrease operative time and increase 
operative success.  
6.1 Intraoperative PTH monitoring 
Intraoperative PTH (IOPTH) monitoring was developed to help guide the extent of surgical 
exploration and parathyroid resection. The most common reason for a failed initial 
operation is missed multigland disease. (Irvin, 1994) IOPTH monitoring is based on the 
assumption that removing the hyperfunctioning gland will cause the PTH level to fall 
appropriately. (Vignali) The half-life of PTH ranges from 3 to 4 minutes and can be 
measured easily with a quick immunoradiometric assay or with a two-site antibody 
immunochemiluminometric assay. (Irvin, 1994)  
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The Miami group was the first to describe IOPTH monitoring in conjunction with a 
minimally invasive parathyroidectomy. The PTH is measured twice before the parathyroid 
is resected (preincision and preexcision). The higher value of the two is used. Once the 
parathyroid is removed, the PTH is measured again at 5 and 10 minutes. PTH levels are 
drawn either from a peripheral vein or from an internal jugular vein. Additional intervals 
are also measured if deemed necessary by the operating surgeon. (Boggs) A successful 
resection is defined as a  50% drop in PTH from baseline at 10 minutes after parathyroid 
removal. (Boggs, Vignali, Irvin, 1994) A fall in PTH < 50% indicates inadequate resection 
and necessitates further exploration. (Boggs) The success of minimally invasive 
parathyroidectomies and IOPTH monitoring is now reported as 98%, a rate equivalent to the 
standard bilateral neck exploration. (Vignali) However, IOPTH also results in a false-
positive rate of 3% to 24% (the rate is lower with adenomas and higher with multigland 
disease), leading to failed operations. (Yang) 
IOPTH monitoring is an important adjunct to surgery, especially with negative or 
discordant results of preoperative imaging studies. (Gawande) It can guide the operation 
and minimize unnecessary bilateral neck dissections. It is also beneficial in reoperative 
parathyroidectomies, when it is necessary to find the source of disease. Higher success rates 
(from 76% to 94%) have been noted for reoperative parathyroidectomies that incorporate 
IOPTH monitoring. (Irvin, 1999) 
6.2 Gamma probes  
Minimally invasive radio-guided surgery is now performed for patients with PHPT. The 
technique involves preoperative IV injection of 37MBq of MIBI). (Rubello) Then the 11-mm 
gamma probe is used to scan the patient’s neck, near the site of the presumed adenoma, in 
order to obtain a preoperative background gamma count. After the surgical field is exposed, 
the radioactivity of the parathyroid adenoma, thyroid, and surrounding area are all re-
measured. An adenoma is defined as an ex-vivo parathyroid with at least 20% of the 
background radioactivity. The empty parathyroid bed is also checked for radioactivity, and 
any remaining tissue should only have up to 3% of the radioactivity of the adenoma. 
(Rubello, Howe) Some clinicians opt to perform intraoperative PTH measurements as well, to 
enhance their accuracy. (Rubello)  
One of the benefits of using the gamma probe is that it assists in localizing ectopic adenomas 
and those located deep in the neck. It allows re-checking not only of the operative field for 
radioactivity after removal of the presumed source but also of the removed tissue, in order 
to be certain that the hyperactive adenoma has been removed. (Rubello) Technically, the 
gamma probe is also helpful with a very small incision, which makes visualization of glands 
much more difficult than in a traditional bilateral neck exploration. It is also helpful for 
reoperations, because scar tissue makes finding the adenoma of interest much more difficult. 
(Jaskowiak) Some clinicians find that the gamma probe is also more cost-effective in that it 
decreases the number of frozen sections. (Jaskowiak) However, most agree that it is possible 
to miss multigland disease with this technique. (Rubello) About 2% to 3% of patients require 
conversion to a bilateral neck exploration, most frequently because intraoperative PTH 
levels failed to decrease. (Rubello, Jaskowiak)  
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6.3 Intraoperative assessment  
6.3.1 Frozen section analysis 
Intraoperative frozen sections for PHPT are helpful in many situations. Parathyroids can be 
difficult to grossly differentiate from other tissues, such as fat, thymus, thyroid, and lymph 
nodes. Despite advances in preoperative imaging studies, their accuracy remains limited; 
sampling parathyroids intraoperatively, before excision, may be necessary to look for 
hypercellularity. (Osamura) Frozen section analysis allows for rapid confirmation of the 
tissue, and especially for differentiation between parathyroid and non-parathyroid tissue. 
Like any other test, frozen sections have limitations. During the freezing process, the tissue 
can be damaged and distorted, leading to a delay in diagnosis (while awaiting final 
pathology results) or to an error in diagnosis. In small glands, the sample may not be large 
enough for an adequate diagnosis (although this is not an issue with enlarged, abnormal 
glands). It can be very difficult to differentiate thyroid nodules from intrathyroidal 
parathyroids. (Westra) With the advent of minimally invasive parathyroidectomies, frozen 
sections are no longer used to assess non-affected glands. (Osamura)  
At some institutions, instead of frozen section analysis, scrape cytology is performed to 
assess the parathyroids intraoperatively. Scrape cytology requires few instruments and little 
equipment, which makes it a more economical test. One study reported its sensitivity to be 
86%. Its main drawback is that, in very small glands, obtaining an adequate sample may be 
more difficult. Occasionally, the sample is misinterpreted as thyroid tissue. Still, if frozen 
sections are not available, scrape cytology can be very helpful. (Rohaizak)  
6.3.2 Needle aspiration and PTH analysis 
An alternative to frozen section analysis for intraoperative identification of parathyroids is 
needle aspiration with rapid PTH analysis. This method is more cost-effective than frozen 
section analysis because it allows for intraoperative identification without the need for 
pathologic evaluation. It uses the same technique as IOPTH monitoring, but requires much 
less tissue for diagnosis. Some groups advocate this method for intraoperative confirmation 
of PHPT, while others use it to confirm that the removed tissue is parathyroid tissue. Some 
have raised the concern that this method can damage normal parathyroids, yet no evidence 
of this effect exists. Needle aspiration for PTH can also be used preoperatively by 
percutaneously aspirating a presumed parathyroid under imaging guidance, in order to 
confirm that a visualized neck nodule is a parathyroid. (Chan RK) 
The technique for needle aspiration involves a 25-gauge needle on a 3-cc syringe filled with 1.0 
mL normal saline solution. The PTH level is determined by the dual-antibody immunoassay 
for intact PTH. The PTH value of the thyroid is used as a control. Aspiration of parathyroids 
have reportedly produced a value greater than 1600 pg/mL; the average PTH of the thyroid is 
87 pg/mL. (Chan RK) Some clinicians, while advocating similar methods of obtaining tissue, 
have shown that more needle passes (20 instead of 10) and a larger biopsy size (1.0-mm3) 
increase accuracy. The method can be performed in vivo or ex vivo. Its sensitivity for 
identifying parathyroid tissue is 99%, using 1,000 pg/mL as the cutoff. (Conrad)  
When this method is performed preoperatively, either a CT or ultrasound scan is obtained 
to identify cervical masses in patients with PHPT or in patients who have recurrent PHPT 
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after an initial operation. Any level of PTH is considered a positive result, because no other 
tissue should contain PTH. Percutaneous aspiration can be performed safely with minimal 
associated complications. Although this method allows for accurate identification of 
parathyroid tissue, the false-negative rate is 13% (likely depending on the needle aspiration 
technique). (Sacks)  
7. Operative techniques 
7.1 Minimally invasive parathyroidectomy (MIP) 
With technical advances in imaging and surgical adjuncts, PHPT is now commonly treated 
with a minimally invasive parathyroidectomy. Most clinicians agree that candidates for a 
minimally invasive parathyroidectomy need to have two concordant preoperative imaging 
studies (typically, sestamibi and ultrasound scans). The operation is usually performed with 
one of the aforementioned surgical adjuncts, which allow for a more focused operation, a 
smaller and more cosmetic incision, less operative risk, and outpatient surgery or the use of 
local anesthesia. Most patients have single-gland disease, so a minimally invasive approach 
seems preferable. (Lorenz)  
7.1.1 Focused parathyroidectomy 
A focused parathyroidectomy entails a targeted exploration, directed by the results of 
preoperative imaging, at the site of the suspected adenoma. All patients undergoing a 
focused parathyroidectomy were thought to possibly have single-gland disease, per 
preoperative imaging. The operation can be performed with IOPTH monitoring or the 
gamma probe. A 2-cm transverse incision is made over the site of the suspected adenoma, at 
the medial border of the ipsilateral sternocleidomastoid muscle. The sternocleidomastoid 
muscle and carotid artery are retracted laterally, and the thyroid is retracted anteromedially. 
If the adenoma is identified, it is circumferentially dissected. If the adenoma is not 
identified, the ipsilateral neck should be explored; conversion to a traditional bilateral 
exploration may be necessary. Although focused parathyroidectomy allows for a smaller 
cosmetic incision, the downside is that conversion to a bilateral neck exploration may 
require a second incision. (Lorenz)  
7.1.2 Unilateral neck exploration 
In a unilateral neck exploration, the incision is half the length of the traditional Kocher 
incision. The skin and subcutaneous layers are divided down through the platysma, and the 
subplatysmal flaps are raised. The median raphe of the strap muscles is divided; the 
ipsilateral strap muscles are retracted laterally; and the thyroid lobe is rotated 
anteromedially. Once the adenoma is identified, it is circumferentially dissected and 
resected. Both parathyroids on the ipsilateral side should be visualized: one normal and one 
abnormal gland should be visualized. However, if both those glands appear normal, or if an 
abnormal adenoma is not localized, the contralateral side must be explored. (Lorenz)  
A unilateral exploration may be performed under local anesthesia. Frequently, this 
operation is coupled with intraoperative adjuncts to help guide the extent of resection. 
(Lorenz) Most groups report similar rates of disease recurrence after unilateral and bilateral 
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neck explorations. The Michigan group reported no incidence of recurrent disease after 
unilateral neck explorations and a follow-up of 4 years. (Lucas) 
7.1.3 Endoscopic parathyroidectomy 
This type of neck exploration uses multiple small incisions to insert endoscopic instruments 
and a camera.(Lorenz) It has several advantages. First, it is a minimally invasive method 
that can treat multigland disease. Second, it magnifies all of the anatomy, making a nerve 
injury less likely. Third, it allows exploration of the mediastinum, if needed, for ectopic 
glands. (Gagner) Its downsides are that the surgeon is unable to use tactile sensation and 
that the patient is prone to hypercarbia and subcutaneous emphysema. (Naitoh)  
An endoscopic parathyroidectomy can be performed in several different ways. Gagner et al. 
devised a method with CO2 insufflation. They use a 2-cm suprasternal incision for a 5-mm 
trocar, and then place 2 to 3 needle trocars and one more 5-mm trocar on the medial aspect 
of the ipsilateral sternocleidomastoid muscle. The camera goes in the 5-mm trocars; the rest 
are working trocars. The area is insufflated to 15 mm Hg. Endoscopic scissors and dissectors 
are used to dissect out the borders of the thyroid and trachea. Clips are used to ligate 
vessels. The specimen is retrieved through an incision of 2 to 3 cm at the maxillary angle. 
Single adenomas as well as multigland disease can be effectively treated with this method.  
Yeung et al. place an 11-mm trocar above the suprasternal notch. The platysma is incised, 
and CO2 is insufflated to 6 to 8 mm Hg. Then a 5-mm trocar is placed near the lower edge of 
the sternocleidomastoid muscle, 2 cm above the incision on the opposite side of the lesion. A 
second 5-mm trocar is placed 2 to 3 cm lateral to the midline incision. One additional trocar, 
if needed, is occasionally placed. Endoscopic scissors are used to create a plane between the 
sternocleidomastoid and the strap muscles. The carotid sheath and thyroid lobe are exposed, 
and the fascia of the thyroid is incised, to mobilize the thyroid anteromedially after dividing 
the middle thyroid vein. Any abnormal parathyroids are identified and resected, then 
removed through the 11-mm port.  
An endoscopic video-assisted parathyroidectomy is also possible. Miccoli et al. described a 
procedure using only CO2 during the initial dissection, in order to avoid hypercarbia and 
subcutaneous emphysema. They make a 1.5-cm incision 1 cm above the sternal notch and 
incise the linea alba to insert a 12-mm trocar toward the side of the adenoma. The area is 
insufflated to 12 mm Hg, in order to dissect the strap muscles away. Then the CO2 is turned 
off, and the space is maintained with retraction. A 5-mm camera is inserted in the same 
incision, as are skin retractors (one lifting the thyroid up and the other retracting laterally). 
The thyrotracheal groove is exposed, and the 2-mm instruments are inserted through a 
small lateral incision. The parathyroid of interest is identified and resected.  
7.1.4 DaVinci-assisted parathyroidectomy 
Robot-assisted parathyroidectomy was first used to assist with removing mediastinal 
parathyroids. (Harvey) The daVinci system has now been used for robotic transaxillary 
parathyroid surgery. A daVinci-assisted parathyroidectomy and an open operation have 
equivalent cure and complication rates. However, the advantages of a daVinci-assisted 
parathyroidectomy include cosmesis (it avoids neck scars), reduced operating times, 
shorter hospital stays, and decreased analgesia requirement. The robotic endoscope has 
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magnification, enabling better visualization than traditional endoscopic procedures. 
Though robotic instrumentation allows more flexible motion than traditional endoscopic 
instruments, it is still more restricted than open surgery. Other limitations include 
difficulties with depth perception, less tactile feedback, and dependence on multiple 
assistants. (Tolley)  
For a daVinci-assisted parathyroidectomy, the patient is positioned supine, with the neck 
extended and the shoulder bolstere. The initial incision is made below the ipsilateral clavicle 
to expose the sternoclavicular junction, long enough for a 12-mm trocar. Dissection 
continues cranially until exposure of the internal jugular vein, carotid artery, and omohyoid 
and sternohyoid muscles. A retractor is used to retract the strap muscles. At this point, the 
posterolateral border of the thyroid is exposed. The other three trocars are then inserted at 
the anterior axillary line. The camera is placed through the infraclavicular trocar. The 
daVinci instruments are placed through the axillary incisions (5-mm trocars). Then, the 
inferior thyroid pole, recurrent laryngeal nerve (RLN), and vascular pedicle of the 
parathyroid gland are exposed. A nerve stimulator may be used to continually identify the 
RLN. A harmonic scalpel is used to dissect the pathologic parathyroid free. Hemostasis is 
obtained, the trocars are removed, and the wounds are closed. (Tolley) 
7.2 Conventional bilateral neck exploration 
7.2.1 Surgical approach 
A traditional bilateral neck exploration is performed through a transverse cervical incision 
(Kocher), about 2 cm above the sternal notch and just below the cricoid cartilage. The 
dissection is carried through the subcutaneous tissue and platysma down to the strap 
muscles, which are opened in the midline and retracted laterally. A self-retaining retractor 
is placed to assist with exposure. The strap muscles are separated from the thyroid. The 
right lobe of the thyroid is dissected bluntly and retracted medially, enabling the surgeon 
to look for the course of the recurrent laryngeal nerve. The middle thyroid vein is 
identified and ligated. The thyroid gland is rotated anteromedially, and the recurrent 
laryngeal nerve is identified near the middle thyroid artery. The superior parathyroid is 
found by slowly dissecting the loose tissue attaching the superior pole of the thyroid. The 
inferior gland is found in the same manner near the inferior thyroid artery. The procedure 
is repeated on the left side. All four glands are accessible through this incision and all four 
glands are viewed. (Johnson) 
Once all four glands are identified, the extent of resection must be decided. If a single 
adenoma is found, it is removed. Two glands are removed if a double adenoma is visually 
confirmed. If all four glands are enlarged, indicating multigland hyperplasia, then a 3.5-
gland resection is performed. All four glands can be biopsied to accurately distinguish 
single-gland from multigland disease. (Lorenz)  
If the parathyroids are not found in their usual location, it is necessary to explore the common 
locations of ectopic glands. Ectopic superior glands may be found in the tracheoesophageal 
groove; in the retropharyngeal or retroesophageal space; posterior mediastinum; in the carotid 
sheath; or within the thyroid itself (intrathyroidal). (Johnson) Ectopic inferior parathyroids are 
typically on the posterior portion of the lower pole of the thyroid, but may be submandibular, 
intrathymic, or intrathyroidal, or may be found in the thyrothymic ligament or anterior 
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mediastinum. (Pyrah) At this point, if the adenoma is still not localized, an ipsilateral 
thyroidectomy is performed. The success rate of a bilateral neck exploration is 95% when 
performed by an experienced endocrine surgeon. (Low) 
7.2.2 Indications  
A bilateral neck exploration should be performed when the results of preoperative 
localizing imaging studies are equivocal or discordant. (Lumachi, 2000) It is also 
recommended for patients with familial PHPT; patients with multiple endocrine neoplasia 
syndrome type I and IIA; and patients who may have a carcinoma. In addition, it should be 
performed when a thyroid resection is planned concomitantly. Obese patients may be more 
likely to require a bilateral neck exploration, because their body habitus may preclude a 
minimally invasive procedure. (Grant)  
7.2.3 Indications for conversion from a minimally invasive parathyroidectomy  
A minimally invasive parathyroidectomy is becoming more common in patients with 
single-gland disease. However, in some patients, it may be necessary to convert from a 
minimally invasive parathyroidectomy to a bilateral neck exploration. The most common 
reason for conversion is failure to appropriately identify a single abnormal gland. 
Conversion is also recommended when surgical adjuncts fail to indicate success (for 
example, the operation is unsuccessful when IOPTH monitoring shows a drop of < 50% in 
the PTH). Note that, if a unilateral neck exploration finds two normal or two abnormal 
glands, it, too, should be converted to a bilateral neck exploration. (Moalem)  
For Initial Surgery 
Equivocal or discordant preoperative imaging results 
Familial PHPT 
Multiple endocrine neoplasia syndrome type I and 
IIA 
Carcinoma 
Concomitant thyroid resection 
Obesity 
For Conversion from Minimally Invasive Surgery 
Failure to identify a single abnormal gland 
Multiple abnormal glands 
Failure of adjuncts to indicate success 
Table 7. Indications for Bilateral Neck Exploration 
8. Complications  
All operations on the parathyroids have potential complications, regardless of the surgical 
approach. Of most concern to patients is the risk of RLN injury leading to vocal cord 
paralysis on the side of the injury. The risk of RLN injury is about 1% in the hands of 
experienced surgeons. Rarely, both RLNs may be injured, resulting in airway obstruction, 
stridor, and the need for a tracheostomy. The superior laryngeal nerve can also be injured, 
which leaves patients hoarse and unable to change the pitch of their voice. (Fewins)  
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Another common risk is postoperative hypocalcemia, which occurs temporarily in 5% of 
patients (because of bone hunger or inadequate PTH secretion from the remaining 
parathyroids as a result of prolonged suppression). In 1% of patients, hypocalcemia is 
permanent, as a consequence of inadvertent injury to the remaining parathyroid(s). 
(Inabnet) Hypocalcemia typically involves perioral numbness or digit tingling and 
paresthesias, but can progress to tetany or stridor. Treatment requires calcium, and often 
vitamin D, supplementation. (Fewins)  
Other, more rare complications include cervical hematomas, injury to the carotid artery, 
dysphagia, deep vein thrombosis, wound infection, and pneumothorax. (Low, Fewins) 
Hematomas are usually secondary to inadequate hemostasis. (Fewins) Symptoms can 
include pain, dysphagia, and respiratory distress. Such patients need to emergently undergo 
reexploration; however, the hematoma needs to be evacuated at the bedside if the patient is 
in respiratory distress. (Fewins) Complications specific to endoscopic parathyroidectomies 
include hypercarbia and extended subcutaneous emphysema. (Lorenz)  
If the patient has significant comorbidities before surgery, the risks of anesthesia can also 
cause complications, including aspiration pneumonia, respiratory failure, cardiac events, 
and even death. (Low) It is important to note that, in the hands of experienced endocrine 
surgeons at high-volume parathyroidectomy centers, postoperative complication rates 
decrease. (Stavrakis)  
Common 
Hypocalcemia 
Injury to the recurrent or 
superior laryngeal nerve 
Rare 
Cervical hematomas 
Injury to the carotid artery 
Dysphagia 
Deep vein thrombosis 
Wound infection 
Pneumothorax 
Table 8. Surgical Complications 
9. Summary 
PHPT is a common disease that is effectively treated by surgery. The many surgical options 
range from a minimally invasive parathyroidectomy to a bilateral neck exploration. 
Regardless of the surgical approach, the likelihood of success is highest with an experienced 
endocrine surgeon at a high-volume center. To reduce the chance of operative failure, 
knowledge of the anatomy and embryology of the parathyroids is paramount. 
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